معرفی
Professor Kathleen A Boyd is a Professor of Health Economics and Director of Research in the School of Health & Wellbeing at the University of Glasgow. She leads the Health Economics for Health Technology Assessment (HEHTA) group and specializes in economic evaluations alongside clinical trials, decision analytic modeling, and HTA for complex interventions. Her work spans oncology, maternal and child health, diagnostics, and public health.
Education:
- BA (Hons) in Economics, University of Strathclyde
- MSc in Health Economics, University of Sheffield
- PhD in Health Economics, University of Glasgow
Research Interests: Methodological advancements in HTA, including pre-trial modeling, cost-effectiveness analysis of public health interventions, and Value of Information Analysis. Her applied work focuses on oncology, smoking cessation, obstetrics, and child health.
Key Contributions: Over 90 publications, including studies on robotic surgery economics, foster care interventions (BeST? Trial), and smoking cessation policies. Lead Health Economics Reviewer for the Scottish Medicines Consortium (SMC). Awards include prestigious grants from NIHR, MRC, and Cancer Research UK.
Grants & Collaborations: Principal investigator on NIHR-funded projects (e.g., HTA 152682, HTA 134350) and academic partnerships with Beatson CRUK Clinical Trials Unit. Active in multi-disciplinary teams designing economic evaluations for clinical trials.
Labs/Teams: Leads the HEHTA group and collaborates internationally on trials like SCOT (colorectal cancer chemotherapy duration) and QUIDS (preterm labor prediction).
